메뉴 건너뛰기




Volumn 66, Issue 27-28, 2010, Pages 4919-4938

Synthesis of dipeptidyl peptidase-4 inhibitors: A brief overview

Author keywords

Antihyperglycemic agents; DPP 4 inhibitors; GLP 1; Oral glucose tolerance test; Plasma glucose; Synthesis; Type 2 diabetes

Indexed keywords

1 [4 METHYL 1 (2 PYRIMIDINYL) 4 PIPERIDYLAMINOACETYL] 2 PYRROLIDINECARBONITRILE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 6 [[2 [[2 (2 CYANO 1 PYRROLIDINYL) 2 OXOETHYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; 8 (3 AMINO 1 PIPERIDINYL) 7 (2 BUTYNYL) 3 METHYL 1 (4 METHYL 2 QUINAZOLINYLMETHYL)XANTHINE; ABT 279; ALOGLIPTIN; AZABICYCLOOCTANYL DERIVATIVE; BETA AMINO ACID; DENAGLIPTIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DP 893; DUTOGLIPTON TARTRATE; E 3024; ER 319711; GLYCOSIDASE INHIBITOR; GRC 8200; ISOLEUCINE THIAZOLIDIDE; LC 150444; LINAGLIPTIN; MELOGLIPTIN; METFORMIN; MP 513; PHX 1149; R 1579; SAXAGLIPTIN; SITAGLIPTIN; SULFONYLUREA; TS 021; UNCLASSIFIED DRUG; VILDAGLIPTIN;

EID: 77954349542     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.04.088     Document Type: Review
Times cited : (56)

References (119)
  • 62
    • 77954348838 scopus 로고    scopus 로고
    • Novel orally active dipeptidyl peptidase IV inhibitors exhibiting potent activity in animal models of diabetes
    • 2005, California CA, USA
    • Narayanan, S. Novel orally active dipeptidyl peptidase IV inhibitors exhibiting potent activity in animal models of diabetes. 4th International Metabolic Diseases Drug Discovery World Summit, 2005, California CA, USA.
    • 4th International Metabolic Diseases Drug Discovery World Summit
    • Narayanan, S.1
  • 63
    • 77954348512 scopus 로고    scopus 로고
    • News release http://www.glenmarkpharma.com/research/clinical-03-mid.html
  • 64
    • 77954349833 scopus 로고    scopus 로고
    • Glenmark Pharmaceuticals Ltd Press Release, February 24 (2006)
    • Glenmark Pharmaceuticals Ltd Press Release, February 24 (2006).
  • 65
    • 77954349683 scopus 로고    scopus 로고
    • Glenmark Pharmaceuticals Ltd Company Presentation, February 04(2005)
    • Glenmark Pharmaceuticals Ltd Company Presentation, February 04(2005).
  • 66
    • 77954348954 scopus 로고    scopus 로고
    • Glenmark Pharmaceuticals Ltd Press Release, September 22(2005)
    • Glenmark Pharmaceuticals Ltd Press Release, September 22(2005).
  • 94
    • 77954348589 scopus 로고    scopus 로고
    • U.S. Patent 2006/0094722
    • Yasuda, N.; Yamazaki, K. U.S. Patent 2006/0094722, 2006.
    • (2006)
    • Yasuda, N.1    Yamazaki, K.2
  • 95
    • 77954349333 scopus 로고    scopus 로고
    • WO 2007/0219178
    • Muramoto, K. WO 2007/0219178, 2007.
    • (2007)
    • Muramoto, K.1
  • 104
    • 77954349764 scopus 로고    scopus 로고
    • R-1438 and R-1579 Roche Holding AG Company communication November 23′
    • Drug development pipeline, R-1438 and R-1579 Roche Holding AG Company communication November 23′ (2006).
    • (2006) Drug Development Pipeline


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.